Sexually diergic hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine infusion, and nicotine withdrawal by mecamylamine in rats

Brain Research Bulletin

Volumn 85, Issue 3-4, 2011, Pages 145-152

  Gentile, Natalie E ^a,d   Andrekanic, Julie D ^a,e   Karwoski, Tracy E ^b   Czambel, R Kenneth ^b   Rubin, Robert T ^c   Rhodes, Michael E ^a  

^a SAINT VINCENT COLLEGE   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e DUQUESNE UNIVERSITY   (United States)

Author keywords

ACTH; CORT; HPA axis; Mecamylamine; Nicotine; Sexual diergism

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; MECAMYLAMINE; NICOTINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTINUOUS INFUSION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HABITUATION; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SINGLE DRUG DOSE; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

EID: 79957808225     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.03.001     Document Type: Article

References (78)

1. al' Absi M. Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse. Int. J. Psychophysiol. 2006, 59:218-227.
2. al' Absi M., Wittmers L.E., Hatsukami D., Westra R. Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke. Psychosom. Med. 2008, 70:928-935.
3. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 1993, 14:76-122.
4. Assenmacher I., Szafarczyk A., Alonso G., Ixart G., Barbanel G. Physiology of neural pathways affecting CRH secretion. Ann. N. Y. Acad. Sci. 1987, 512:149-161.
5. Avissar S., Egozi Y., Sokolovsky M. Biochemical characterization and sex dimorphism of muscarinic receptors in rat adenohypophysis. Neuroendocrinology 1981, 32:303-309.
6. Avissar S., Egozi Y., Sokolovsky M. Studies on muscarinic receptors in mouse and rat hypothalamus: a comparison of sex and cyclical differences. Neuroendocrinology 1981, 32:295-302.
7. Becker J.B., Hu M. Sex differences in drug abuse. Front. Neuroendocrinol. 2008, 29:36-47.
8. Benowitz N.L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin. Pharmacol. Ther. 2008, 83:531-541.
9. Benowitz N.L., Lessov-Schlaggar C.N., Swan G.E., Jacob P. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin. Pharmacol. Ther. 2006, 79:480-488.
10. Benwell M.E., Balfour D.J. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles. Psychopharmacology (Berl.) 1979, 63:7-11.
11. Benwell M.E., Balfour D.J., Birrell C.E. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br. J. Pharmacol. 1995, 114:454-460.
12. Benwell M.E., Balfour D.J., Khadra L.F. Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine. Clin. Investig. 1994, 72:233-239.
13. Blasig J., Herz A., Reinhold K., Zieglgansberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 1973, 33:19-38.
14. Bruijnzeel A.W., Zislis G., Wilson C., Gold M.S. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 2007, 32:955-963.
15. Caggiula A.R., Epstein L.H., Antelman S.M., Saylor S.S., Perkins K.A., Knopf S., Stiller R. Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine. Pharmacol. Biochem. Behav. 1991, 40:53-59.
16. Caldarone B.J., King S.L., Picciotto M.R. Sex differences in anxiety-like behavior and locomotor activity following chronic nicotine exposure in mice. Neurosci. Lett. 2008, 439:187-191.
17. Cam G.R., Bassett J.R. The plasma levels of ACTH following exposure to stress or nicotine. Arch. Int. Pharmacodyn. Ther. 1983, 264:154-167.
18. Cam G.R., Bassett J.R., Cairncross K.D. The action of nicotine on the pituitary-adrenal cortical axis. Arch. Int. Pharmacodyn. Ther. 1979, 237:49-66.
19. Changeux J.P., Bertrand D., Corringer P.J., Dehaene S., Edelstein S., Lena C., Le Novere N., Marubio L., Picciotto M., Zoli M. Brain nicotinic receptors: structure and regulation, role in learning and reinforcement. Brain Res. Brain Res. Rev. 1998, 26:198-216.
20. Chen H., Fu Y., Sharp B.M. Chronic nicotine self-administration augments hypothalamic-pituitary-adrenal responses to mild acute stress. Neuropsychopharmacology 2008, 33:721-730.
21. Coolon R.A., Cain M.E. Effects of mecamylamine on nicotine-induced conditioned hyperactivity and sensitization in differentially reared rats. Pharmacol. Biochem. Behav. 2009, 93:59-66.
22. Dickmann P.J., Mooney M.E., Allen S.S., Hanson K., Hatsukami D.K. Nicotine withdrawal and craving in adolescents: effects of sex and hormonal contraceptive use. Addict. Behav. 2009, 34:620-623.
23. Elliott B.M., Faraday M.M., Phillips J.M., Grunberg N.E. Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats. Pharmacol. Biochem. Behav. 2004, 77:21-28.
24. Faraday M.M., Blakeman K.H., Grunberg N.E. Strain and sex alter effects of stress and nicotine on feeding, body weight, and HPA axis hormones. Pharmacol. Biochem. Behav. 2005, 80:577-589.
25. Favaretto A., Valenca M., Picanco-Diniz D., Antunes-Rodrigues J. Inhibitory role of cholinergic agonists on testosterone secretion by purified rat Leydig cells. Arch. Int. Physiol. Biochim. Biophys. 1993, 101:333-335.
26. File S.E., Kenny P.J., Ouagazzal A.M. Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav. Neurosci. 1998, 112:1423-1429.
27. Fu Y., Matta S.G., Valentine J.D., Sharp B.M. Adrenocorticotropin response and nicotine-induced norepinephrine secretion in the rat paraventricular nucleus are mediated through brainstem receptors. Endocrinology 1997, 138:1935-1943.
28. Gray T.S., Carney M.E., Magnuson D.J. Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 1989, 50:433-446.
29. Hamilton K.R., Berger S.S., Perry M.E., Grunberg N.E. Behavioral effects of nicotine withdrawal in adult male and female rats. Pharmacol. Biochem. Behav. 2009, 92:51-59.
30. Hildebrand B.E., Nomikos G.G., Bondjers C., Nisell M., Svensson T.H. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology (Berl.) 1997, 129:348-356.
31. Hildebrand B.E., Panagis G., Svensson T.H., Nomikos G.G. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area. Neuropsychopharmacology 1999, 21:560-574.
32. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocorticol axis. Endocr. Rev. 1991, 12:118-134.
33. Kageyama K., Suda T. Regulatory mechanisms underlying corticotropin-releasing factor gene expression in the hypothalamus. Endocr. J. 2009, 56:335-344.
34. Keser A., Balkan B., Gozen O., Kanit L., Pogun S. Hippocampal neuronal nitric oxide synthase (nNOS) is regulated by nicotine and stress in female but not in male rats. Brain Res. 2011, 1368:134-142.
35. Koylu E., Demirgoren S., London E.D., Pogun S. Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci. 1997, 61 PL:185-190.
36. Kyerematen G., Owens G., Chattapadhyay B., deBethizy J., Vesell E. Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro. Drug Metab. Dispos. 1988, 16:823-828.
37. Madeira M.D., Lieberman A.R. Sexual dimorphism in the mammalian limbic system. Prog. Neurobiol. 1995, 45:275-333.
38. Malin D.H., Lake J.R., Newlin-Maultsby P., Roberts L.K., Lanier J.G., Carter V.A., Cunningham J.S., Wilson O.B. Rodent model of nicotine abstinence syndrome. Pharmacol. Biochem. Behav. 1992, 43:779-784.
39. Matta S., McCoy J., Foster C., Sharp B. Nicotinic agonists administered into the fourth ventricle stimulate norepinephrine secretion in the hypothalamic paraventricular nucleus: an in vivo microdialysis study. Neuroendocrinology 1995, 61:383-392.
40. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., Craig C.R., Collins A.C., Damaj M.I., Donny E.C., Gardiner P.S., Grady S.R., Heberlein U., Leonard S.S., Levin E.D., Lukas R.J., Markou A., Marks M.J., McCallum S.E., Parameswaran N., Perkins K.A., Picciotto M.R., Quik M., Rose J.E., Rothenfluh A., Schafer W.R., Stolerman I.P., Tyndale R.F., Wehner J.M., Zirger J.M. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl.) 2007, 190:269-319.
41. Matta S.G., Beyer H.S., McAllen K.M., Sharp B.M. Nicotine elevates rat plasma ACTH by a central mechanism. J. Pharmacol. Exp. Ther. 1987, 243:217-226.
42. Matta S.G., Fu Y., Valentine J.D., Sharp B.M. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998, 23:103-113.
43. Mendelson J.H., Goletiani N., Sholar M.B., Siegel A.J., Mello N.K. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology 2008, 33:749-760.
44. Mendelson J.H., Sholar M.B., Goletiani N., Siegel A.J., Mello N.K. Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men. Neuropsychopharmacology 2005, 30:1751-1763.
45. Mochizuki T., Villemagne V.L., Scheffel U., Dannals R.F., Finley P., Zhan Y., Wagner H.N., Musachio J.L. Nicotine induced up-regulation of nicotinic receptors in CD-1 mice demonstrated with an in vivo radiotracer: gender differences. Synapse 1998, 30:116-118.
46. Moidel M.A., Belz E.E., Czambel R.K., Rubin R.T., Rhodes M.E. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses. J. Pharmacol. Toxicol. Methods 2006, 53:264-271.
47. Okuda H., Shioda S., Nakai Y., Nakayama H., Okamoto M., Nakashima T. The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat. Neurosci. Lett. 1993, 161:183-186.
48. Öztas B. Sex and blood-brain barrier. Pharmacol. Res. 1998, 37:165-167.
49. Paterson D., Nordberg A. Neuronal nicotinic receptors in the human brain. Prog. Neurobiol. 2000, 61:75-111.
50. Pogun S., Yararbas G. Sex differences in nicotine action. Handb. Exp. Pharmacol. 2009, 261-291.
51. Pomerleau O.F., Pomerleau C.S., Snedecor S.M., Gaulrapp S., Brouwer R.N., Cameron O.G. Depression, smoking abstinence and HPA function in women smokers. Hum. Psychopharmacol. 2004, 19:467-476.
52. Porcu P., Sogliano C., Cinus M., Purdy R.H., Biggio G., Concas A. Nicotine-induced changes in cerebrocorticalneuroactive steroids and plasma corticosterone concentrations in the rat. Pharmacol. Biochem. Behav. 2003, 74:683-690.
53. Prince F.P. Ultrastructural evidence of indirect and direct autonomic innervation of human Leydig cells: comparison of neonatal, childhood and pubertal ages. Cell Tissue Res. 1992, 269:383-390.
54. Rhodes M.E., Billings T.E., Czambel R.K., Rubin R.T. Pituitary-adrenal responses to cholinergic stimulation and acute mild stress are differentially elevated in male and female M(2) muscarinic receptor knockout mice. J. Neuroendocrinol. 2005, 17:817-826.
55. Rhodes M.E., Kennell J.S., Belz E.E., Czambel R.K., Rubin R.T. Rat estrous cycle influences the sexual diergism of HPA axis stimulation by nicotine. Brain Res. Bull. 2004, 64:205-213.
56. Rhodes M.E., McKlveen J.M., Ripepi D.R., Gentile N.E. Hypothalamic-pituitary-adrenal cortical axis. Hormones/Behavior Relations of Clinical Importance - Endocrine Systems Interacting with Brain and Behavior 2009, Academic Press/Elsevier, NY. 1st ed. R.T. Rubin, D. Pfaff (Eds.).
57. Rhodes M.E., O'Toole S.M., Czambel R.K., Rubin R.T. Male-female differences in rat hypothalamic-pituitary-adrenal axis responses to nicotine stimulation. Brain Res. Bull. 2001, 54:681-688.
58. Rhodes M.E., O'Toole S.M., Wright S.L., Czambel R.K., Rubin R.T. Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism. Brain Res. Bull. 2001, 54:101-113.
59. Rhodes M.E., Rubin R.T. Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review. Brain Res. Brain Res. Rev. 1999, 30:135-152.
60. Rhodes M.E., Rubin R.T., McKlveen J.M., Karwoski T.E., Fulton B.A., Czambel R.K. Pituitary-adrenal responses to oxotremorine and acute stress in male and female M1 muscarinic receptor knockout mice: comparisons to M2 muscarinic receptor knockout mice. J. Neuroendocrinol. 2008, 20:617-625.
61. Rivier C. Role of gaseous neurotransmitters in the hypothalamic-pituitary-adrenal axis. Ann. N. Y. Acad. Sci. 2001, 933:254-264.
62. Rivier C., Smith M., Vale W. Regulation of Adrenocorticotropic Hormone (ACTH) Secretion by Corticotropin Releasing Factor (CRF) 1990, CRC Press, Boca Raton.
63. Roche D.J., Childs E., Epstein A.M., King A.C. Acute HPA axis response to naltrexone differs in female vs. male smokers. Psychoneuroendocrinology 2009.
64. Rohleder N., Kirschbaum C. The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. Int. J. Psychophysiol. 2006, 59:236-243.
65. Saija A., Princi P., D'Amico N., De Pasquale R., Costa G. Aging and sex influence the permeability of the blood-brain barrier in the rat. Life Sci. 1990, 47:2261-2267.
66. Salminen O., Seppa T., Gaddnas H., Ahtee L. Effect of acute nicotine on Fos protein expression in rat brain during chronic nicotine and its withdrawal. Pharmacol. Biochem. Behav. 2000, 66:87-93.
67. Sharp B.M., Beyer H.S. Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J. Pharmacol. Exp. Ther. 1986, 238:486-491.
68. 2+ in vasopressin neurons. Neurosci. Res. 1997, 29:311-318.
69. Shram M.J., Siu E.C., Li Z., Tyndale R.F., Lê A.D. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats. Psychopharmacology (Berl.) 2008, 198:181-190.
70. Sithichoke N., Marotta S.F. Cholinergic influences on hypothalamic-pituitary-adrenocortical activity of stressed rats: an approach utilizing agonists and antagonists. Acta. Endocrinol. (Copenh.) 1978, 89:726-736.
71. Stefenson A., Owman C., Sjoberg N.O., Sporrong B., Walles B. Comparative study of the autonomic innervation of the mammalian ovary, with particular regard to the follicular system. Cell Tissue Res. 1981, 215:47-62.
72. van Londen L., Goekoop J.G., van Kempen G.M., Frankhuijzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., De Wied D. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 1997, 17:284-292.
73. Vizi E., Lendvai B. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Rev. 1999, 30:219-235.
74. Whitnall M. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol. 1993, 40:573-629.
75. Wilmouth C.E., Spear L.P. Withdrawal from chronic nicotine in adolescent and adult rats. Pharmacol. Biochem. Behav. 2006, 85:648-657.
76. Wing V.C., Shoaib M. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. Psychopharmacology (Berl.) 2007, 195:303-313.
77. Yilmaz O., Kanit L., Okur B.E., Pogun S. Effects of nicotine on active avoidance learning in rats: sex differences. Behav. Pharmacol. 1997, 8:253-260.
78. Yu G., Chen H., Zhao W., Matta S.G., Sharp B.M. Nicotine self-administration differentially regulates hypothalamic corticotropin-releasing factor and arginine vasopressin mRNAs and facilitates stress-induced neuronal activation. J. Neurosci. 2008, 28:2773-2782.